According to the Huaxi Securities Research Report, benefiting from a consolidated operating base and a recovery in the equity market, China People's Insurance's net profit for the first three quarters of 2024 is expected to be 338.30-37.931 billion yuan, an increase of 133.27-17.428 billion yuan compared with the same period last year, and an increase of 65%-85% over the previous year. The Group's business structure is continuously optimized, risk prevention and control is strong and effective, and the results of cost reduction and efficiency are remarkable. While consolidating its operating foundation, the Group achieved a significant year-on-year increase in total investment income and a significant increase in net profit compared to the same period last year due to the impact of the recovery in the capital market. By the end of 2024H1, the company's transactional financial assets/owners' equity ratio and stock investment/owners' equity ratio were 96%/13% respectively. Although lower than other listed insurers, it is still expected to fully benefit from the recovery in the stock market. Maintain a “buy” rating.

According to the Huaxi Securities Research Report, benefiting from a consolidated operating base and a recovery in the equity market, China People's Insurance's net profit for the first three quarters of 2024 is expected to be 338.30-37.931 billion yuan, an increase of 133.27-17.428 billion yuan compared with the same period last year, and an increase of 65%-85% over the previous year. The Group's business structure is continuously optimized, risk prevention and control is strong and effective, and the results of cost reduction and efficiency are remarkable. While consolidating its operating foundation, the Group achieved a significant year-on-year increase in total investment income and a significant increase in net profit compared to the same period last year due to the impact of the recovery in the capital market. By the end of 2024H1, the company's transactional financial assets/owners' equity ratio and stock investment/owners' equity ratio were 96%/13% respectively. Although lower than other listed insurers, it is still expected to fully benefit from the recovery in the stock market. Maintain a “buy” rating.